Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sickle Cell Disease Without Crisis”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Large-scale testing (Phase 3)Ended earlyNCT00102791
What this trial is testing

A Stratified Sickle Event Randomized Trial (ASSERT)

Who this might be right for
Sickle Cell Disease
Icagen 297
Testing effectiveness (Phase 2)Ended earlyNCT04028700
What this trial is testing

The Impact of Oxidative Stress on Erythrocyte Biology

Who this might be right for
Sickle Cell Disease Without Crisis
University of North Carolina, Chapel Hill 8
Post-approval studies (Phase 4)Study completedNCT04662931
What this trial is testing

An Indian Multi-centric Phase IV Study to Assess the Safety of Crizanlizumab in Sickle Cell Disease Patients

Who this might be right for
Sickle Cell Disease (SCD)
Novartis Pharmaceuticals 140
Large-scale testing (Phase 3)Active Not RecruitingNCT03814746
What this trial is testing

Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease Patients

Who this might be right for
Sickle Cell Disease (SCD)
Novartis Pharmaceuticals 254
Not applicableStudy completedNCT06886477
What this trial is testing

Sickle Cell, Pain and Mediterranean Diet

Who this might be right for
Sickle CellSickle Cell DiseaseSickle Cell Disease Without Crisis+1 more
University of Illinois at Chicago 37
Testing effectiveness (Phase 2)Study completedNCT03264989
What this trial is testing

Pharmacokinetics and Pharmacodynamics Study of SEG101 (Crizanlizumab) in Sickle Cell Disease (SCD) Patients With Vaso- Occlusive Crisis (VOC)

Who this might be right for
Sickle Cell Disease (SCD)
Novartis Pharmaceuticals 57
Early research (Phase 1)Study completedNCT02989701
What this trial is testing

Pilot and Feasibility Trial of Plerixafor for Hematopoietic Stem Cell (HSC) Mobilization in Patients With Sickle Cell Disease Pilot and Feasibility Trial of Plerixafor for Hematopoietic Stem Cell (HSC) Mobilization in Patients With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease Without Crisis
Alessandra Biffi 6
Testing effectiveness (Phase 2)Study completedNCT01895361
What this trial is testing

Study to Assess Safety and Impact of SelG1 With or Without Hydroxyurea Therapy in Sickle Cell Disease Patients With Pain Crises

Who this might be right for
Sickle Cell Disease
Reprixys Pharmaceutical Corporation 198
Testing effectiveness (Phase 2)Study completedNCT03474965
What this trial is testing

Study of Dose Confirmation and Safety of Crizanlizumab in Pediatric Sickle Cell Disease Patients

Who this might be right for
Sickle Cell Disease (SCD)
Novartis Pharmaceuticals 117
Large-scale testing (Phase 3)Looking for participantsNCT06439082
What this trial is testing

Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

Who this might be right for
Sickle Cell Disease
Novartis Pharmaceuticals 354